CenTrial Logo

Clinical Trial finds that Relugolix improves Quality of Life for Uterine Fibroid Patients


Clinical trial finds relgolix improves quality of life for uterine fibroid patients

Are you a woman feeling distressed due to uterine fibroids? Does this burdensome disease affect your daily activities? If so, this clinical trial evaluates a drug to help alleviate some of your symptoms and improve your quality of life.

clinical trial has investigated the effectiveness of a drug regimen called Relugolix combination therapy for reducing symptoms and improving quality of life in women with troublesome fibroids.

Uterine fibroids are non-cancerous growths that develop in the uterus, affecting millions of women worldwide. They can cause heavy periods, pelvic pain, and discomfort. The standard treatment options for fibroids include surgery and medication, which often come with side effects and risks.

A treatment regimen has gained popularity for managing women with symptomatic fibroids. This regimen, called Relugolix combination therapy, consists of three drugs given once daily:
  1. 40 mg relugolix
  2. 1 mg estradiol        
  3. 0.5 mg norethindrone acetate

Relugolix is a medication that works by reducing the amount of estrogen and progesterone in the body, which are hormones that stimulate the growth of fibroids. However, strong clinical data on the effectiveness of this combination in reducing fibroid symptoms and improving health-related quality of life in these women is lacking.

A clinical trial has attempted to measure these variables in women with uterine fibroids.

The clinical study, called the LIBERTY randomized trials, consisted of two replicate clinical trials named LIBERTY 1 and LIBERTY 2. These trials evaluated the use of relugolix combination therapy for treating fibroids. These trials focused on the following aspects of daily life: concern, activities, energy or mood, control, self-consciousness, and sexual function. Additionally, they measured the severity of symptoms and the impact of uterine fibroids on physical and social activities.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The clinical study involved 509 women with fibroids who were randomly assigned to receive either relugolix combination therapy or a placebo. The participants were followed for up to 24 weeks, and their symptoms and quality of life were evaluated using standardized questionnaires.

The results of the clinical trial showed that women who received relugolix combination therapy had significant improvements in their quality of life compared to those who received a placebo. They also reported a reduction in symptoms of fibroids, such as heavy bleeding and pelvic pain, and had better overall physical and mental health.

The clinical study also found that the relugolix combination therapy was safe and well-tolerated, with few side effects reported.

In conclusion, the findings of the LIBERTY clinical trials suggest that relugolix combination therapy may be a promising new treatment option for women with uterine fibroids. It may offer a safe and effective alternative to surgery and other medications, improving the quality of life for millions of women worldwide. Women considering relugolix combination therapy should discuss the potential risks and benefits with their healthcare provider.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.